about
Polyphosphoinositides suppress the adhesion of Haemophilus influenzae to pharyngeal cellsHigh-resolution structures of Neotermes koshunensis β-glucosidase mutants provide insights into the catalytic mechanism and the synthesis of glucoconjugatesInhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharidesPrebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces.Biotechnological approaches to fight pathogens at mucosal sites.Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tractBioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsA glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsStreptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase.Mass spectrometric detection of multiple extended series of neutral highly fucosylated N-acetyllactosamine oligosaccharides in human milkFighting infectious diseases with inhibitors of microbial adhesion to host tissues.An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.Carbohydrate-based therapeutics.Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.Probiotics in marine larviculture.Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.Microbial adhesion of Cryptosporidium parvum sporozoites: purification of an inhibitory lipid from bovine mucosa.ASAS Centennial Paper: Developments and future outlook for preharvest food safety.Prebiotics in chronic intestinal inflammation.Cytotoxicity, phytochemical analysis and antioxidant activity of crude extracts from rhizomes of Elephantorrhiza elephantina and Pentanisia prunelloides.Production of chitooligosaccharides and their potential applications in medicineReceptor mimicry as novel therapeutic treatment for biothreat agents.Membrane applications in functional foods and nutraceuticals.Capability of yeast derivatives to adhere enteropathogenic bacteria and to modulate cells of the innate immune system.LC-MS/MS analysis of permethylated free oligosaccharides and N-glycans derived from human, bovine, and goat milk samples.Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a live-bacteria application of surface plasmon resonance.A novel approach to the recovery of biologically active oligosaccharides from milk using a combination of enzymatic treatment and nanofiltration.Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans.Efficacy of the antiadhesin octyl O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-(1-4)-2-O-propyl-beta-D-galactopyranoside (Fimbrigal-P) in a rat oral candidiasis model.Adherence of Streptococcus pneumoniae to respiratory epithelial cells is inhibited by sialylated oligosaccharides.Pectic oligosaccharides from agricultural by-products: production, characterization and health benefits.Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis.Effect of different feed ingredients and additives on IPEC-J2 cells challenged with an enterotoxigenic Escherichia coli strainAdherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.Oligosaccharide-mediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro.Effects of Dietary Zinc Pectin Oligosaccharides Chelate Supplementation on Growth Performance, Nutrient Digestibility and Tissue Zinc Concentrations of Broilers.Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells.Human milk oligosaccharides: only the breast.
P2860
Q24792877-9D290BA2-E56B-4E87-B5E0-F21BEA4F8F29Q27681684-4F177FA4-D9EC-41DC-8DEC-A5D55919487AQ30452853-1B8C1262-799C-4FEB-8495-EFE3DC57813CQ33432307-28437595-2401-482D-A5F9-DB296E29D4ACQ34074980-580DF4DF-FB2C-498E-A287-6241AAC4803EQ34351883-24E17F55-5DA4-47EC-AF89-602C15F2E1A5Q34443520-08D69163-D92B-4F0A-8363-3D82F0AC3F60Q34518407-EE316EC6-66B9-4A8A-B2B7-2507C7CE4535Q34524965-BB4F25C9-648D-4AA7-987D-4729B4F40C6BQ34581867-074928D0-1ABB-482F-B1ED-B1D0E738E5A1Q34641487-A8657857-30EA-45EC-92D9-D2C1330389BBQ34680458-5F59632A-EC2A-429E-8171-CF5E60F741B6Q35611039-3564D364-79C3-4D42-8109-AF1F93D2A2CFQ35824873-55370FD1-36AD-4F09-ABEF-4E629DDBCB23Q36315525-CCA9AEE9-1E48-4472-A3ED-00422C69EDEFQ36440558-A2CBFA05-4F20-493A-A855-A9717DFAB986Q36735162-AA85D927-3F54-425E-900F-38B46ADF72E0Q36894391-826C0B24-2DC3-4DD6-8EAF-CDE6C901FB81Q36965719-277F3E8F-A673-4C53-BF68-5E1D43C8DD31Q37245624-743A1163-94E6-410A-BC71-576DE9CCF647Q37285115-B9E03731-4ECE-4F1B-8C72-35DE74275D05Q37642657-A2443057-E2B3-4A3D-A097-5B10E844BC34Q37766095-8671EF70-C71F-40A8-9446-0BDE0D319CD9Q37843686-CD89D0A7-5FDA-4A73-8F82-E0392D72616DQ37983882-3E70BDEF-B390-4BC4-AC9A-2D15A29BA71FQ38012063-F49CC1A6-6207-4774-926E-07F7E612FF72Q38293319-544F34D1-497F-41FB-9412-B6733CFC269CQ38300142-02066FF1-3C8F-4277-922C-27FDF4E92C6AQ38311223-522363B6-C858-4944-AABF-6BBCDABBD12EQ38323210-87688123-05A2-4899-A3DA-1DD5675930C8Q38324412-D5864BC4-71C4-4519-AC01-AD99100D93F9Q38338762-7953F211-83BD-457D-BA7B-24A1BE6FFA97Q38340151-ED472E02-4127-4145-AB25-BFA11593DF4DQ38804347-276A0BA2-D3C7-4286-9C67-65D740FAB045Q38843703-7D9FEC1E-6DEC-4E64-B542-E67CB65B8F37Q39598001-DFC3F15C-3989-4E3A-8579-DC545D41C3FDQ39910611-4B7B5F0F-11B1-449E-81F3-9F0C7C0506F2Q39964718-DB49599D-25F3-4006-A235-107126FF30ACQ40867227-85B16E13-6CE0-45DE-B632-92E1C41B95BDQ40884736-4605026E-AE0F-4DE3-8132-E37888BB26FD
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Oligosaccharide anti-infective agents.
@en
type
label
Oligosaccharide anti-infective agents.
@en
prefLabel
Oligosaccharide anti-infective agents.
@en
P1433
P1476
Oligosaccharide anti-infective agents.
@en
P304
P356
10.1016/S0140-6736(96)90150-6
P407
P577
1996-04-01T00:00:00Z